Back to Stakeholders
Octarine Bio is a Danish synthetic biology company producing psilocybin and other neuroactive compounds via proprietary yeast fermentation. Founded in Copenhagen, the company raised $11M from 13 investors including DSM-Firmenich and has partnered with Clerkenwell Health to supply GMP psilocybin for clinical trials. Octarine Bio's platform is based on engineering yeast to express the biosynthetic pathway for psilocybin and related alkaloids.
Drug Pipeline
1Biosynthetic psilocybin
PsilocybinDiscovery
GMP psilocybin produced via engineered yeast fermentation; clinical supply partnership with Clerkenwell Health.
Quick Facts
- Type
- Private Biotech
- Lead Stage
- Discovery
- Website
- Visit